Patents by Inventor Ángela Moya Pérez

Ángela Moya Pérez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170189456
    Abstract: The invention relates to a strain of Bacteroides uniformes with registration number CECT 7771, and to the cellular constituents, metabolites and/or secreted molecules thereof. The invention also relates to a composition (nutritional or pharmaceutical) comprising at least one of the previous products. The invention further relates to the use of a strain of Bacteroides uniforms, preferably CECT 7771, or of the cellular constituents, metabolites and/or secreted molecules of said strain, or of a composition comprising same, for the prevention and/or treatment of alterations such as excess weight, obesity, adipocyte hypertrophy, hepatic steatosis or fatty liver, dyslipidemia, hyperglycemia, insulin resistance and diabetes, metabolic syndrome, hypertension, cardiovascular diseases, dysfunction of the immune system, reduced defences against infections, and imbalance in the composition of the intestinal microbiota.
    Type: Application
    Filed: March 14, 2017
    Publication date: July 6, 2017
    Inventors: Yolanda Sanz Herranz, Paola Gauffin Cano, Yolanda Arlette Santacruz, Angela Moya Perez, Moises Laparra Llopis
  • Patent number: 9636366
    Abstract: The invention relates to a strain of Bacteroides uniformes with registration number CECT 7771, and to the cellular constituents, metabolites and/or secreted molecules thereof. The invention also relates to a composition (nutritional or pharmaceutical) comprising at least one of the previous products. The invention further relates to the use of a strain of Bacteroides uniforms, preferably CECT 7771, or of the cellular constituents, metabolites and/or secreted molecules of said strain, or of a composition comprising same, for the prevention and/or treatment of alterations such as excess weight, obesity, adipocyte hypertrophy, hepatic steatosis or fatty liver, dyslipidemia, hyperglycemia, insulin resistance and diabetes, metabolic syndrome, hypertension, cardiovascular diseases, dysfunction of the immune system, reduced defenses against infections, and imbalance in the composition of the intestinal microbiota.
    Type: Grant
    Filed: May 16, 2013
    Date of Patent: May 2, 2017
    Assignee: Consejo Superior de Investigaciones Cientificas
    Inventors: Yolanda Sanz Herranz, Paola Gauffin Cano, Yolanda Arlette Santacruz, Ángela Moya Pérez, Moisés Laparra Llopis
  • Publication number: 20150216913
    Abstract: The invention relates to a strain of Bacteroides uniformes with registration number CECT 7771, and to the cellular constituents, metabolites and/or secreted molecules thereof. The invention also relates to a composition (nutritional or pharmaceutical) comprising at least one of the previous products. The invention further relates to the use of a strain of Bacteroides uniformes, preferably CECT 7771, or of the cellular constituents, metabolites and/or secreted molecules of said strain, or of a composition comprising same, for the prevention and/or treatment of alterations such as excess weight, obesity, adipocyte hypertrophy, hepatic steatosis or fatty liver, dyslipidemia, hyperglycemia, insulin resistance and diabetes, metabolic syndrome, hypertension, cardiovascular diseases, dysfunction of the immune system, reduced defenses against infections, and imbalance in the composition of the intestinal microbiota.
    Type: Application
    Filed: May 16, 2013
    Publication date: August 6, 2015
    Inventors: Yolanda Sanz Herranz, Paola Gauffin Cano, Yolanda Arlette Santacruz, Moisés Laparra Llopis, Ángela Moya Pérez